Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria

BACKGROUND: The contrast between a high prevalence of chronic kidney disease (CKD) and the low incidence of end-stage renal disease highlights the need for new biomarkers of progression beyond albuminuria testing. Urinary proteomics is a promising method, but more studies focusing on progression rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Øvrehus, Marius A, Zürbig, Petra, Vikse, Bjørn E, Hallan, Stein I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528848/
https://www.ncbi.nlm.nih.gov/pubmed/26257595
http://dx.doi.org/10.1186/s12014-015-9092-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528848/
https://www.ncbi.nlm.nih.gov/pubmed/26257595
http://dx.doi.org/10.1186/s12014-015-9092-7

Ejemplares similares